Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.29M Buy
11,683
+48
+0.4% +$12.1K 0.86% 13
2026
Q1
$2.82M Buy
11,635
+43
+0.4% +$11.6K 0.86% 13
2025
Q4
$3.43M Buy
11,592
+51
+0.4% +$15.3K 1.03% 13
2025
Q3
$3.26M Buy
11,541
+51
+0.4% +$13.3K 1% 13
2025
Q2
$3.39M Buy
11,490
+49
+0.4% +$12.6K 1.13% 12
2025
Q1
$2.84M Buy
11,441
+7,013
+158% +$1.72M 1% 12
2024
Q4
$973K Buy
4,428
+5
+0.1% +$1.11K 0.33% 26
2024
Q3
$978K Buy
4,423
+256
+6% +$50.2K 0.34% 27
2024
Q2
$730K Buy
4,167
+7
+0.2% +$1.22K 0.27% 31
2024
Q1
$794K Buy
4,160
+6
+0.1% +$1.09K 0.3% 29
2023
Q4
$679K Buy
4,154
+8
+0.2% +$1.21K 0.3% 29
2023
Q3
$582K Buy
4,146
+8
+0.2% +$1.14K 0.28% 31
2023
Q2
$554K Buy
4,138
+157
+4% +$20.3K 0.28% 33
2023
Q1
$522K Buy
3,981
+13
+0.3% +$1.74K 0.3% 32
2022
Q4
$559K Buy
3,968
+11
+0.3% +$1.52K 0.34% 29
2022
Q3
$470K Buy
3,957
+153
+4% +$20.1K 0.33% 31
2022
Q2
$537K Buy
3,804
+9
+0.2% +$1.22K 0.37% 29
2022
Q1
$493K Sell
3,795
-88
-2% -$11.5K 0.34% 33
2021
Q4
$519K Buy
+3,883
New +$487K 0.37% 35

Other funds holding IBM

CJM Wealth Advisers's IBM Position: Q2 2026 in Review

CJM Wealth Advisers increased its IBM (IBM) stake by 0.41% in Q2 2026, buying an estimated $12.1K and bringing the position to 11,683 shares worth $3.29M. The position accounts for 0.86% of the portfolio, ranked #13.

CJM Wealth Advisers first reported a position in IBM in Q4 2021 and has held it in 19 quarters since. The position peaked at $3.43M in Q4 2025. 804 funds tracked by Wall St. Rank hold IBM as of Q2 2026.

  • CJM Wealth Advisers held 11,683 shares of IBM worth $3.29M as of Q2 2026.
  • CJM Wealth Advisers bought 48 IBM shares in Q2 2026, an estimated $12.1K.
  • IBM made up 0.86% of CJM Wealth Advisers's portfolio in Q2 2026, its #13 holding.
  • CJM Wealth Advisers first reported a position in IBM in Q4 2021 and has held it in 19 quarters since.
  • CJM Wealth Advisers's IBM position peaked at $3.43M in Q4 2025.
  • 804 funds tracked by Wall St. Rank held IBM as of Q2 2026.

Based on CJM Wealth Advisers's 13F filing for Q2 2026, filed 17 Jul 2026.